Mass. commissioner of public health pushes back on RFK Jr.'s vaccine skepticism
“We need to be resolute," says Robbie Goldstein, the state commissioner of public health. "Vaccines are safe, vaccines are effective, vaccines are the best way for parents to protect their children from measles.”
-
As more teens overdose on fentanyl, schools face a drug crisis unlike any other
Fentanyl-related teen overdose deaths nearly tripled from 2019 to 2021. As the school year gets under way, families in mourning urge education leaders to respond. -
Distrust undermined the U.S. pandemic response. Now, it continues to erode healthcare
High levels of distrust undermined the country's pandemic response and possibly caused half a million deaths. Distrust continues to erode healthcare, diminish access and give old diseases a chance. -
New variants, boosters and more: Your expert guide to COVID-19 as fall approaches
Boston health experts say the updated COVID-19 vaccines will be important to prevent another surge. -
Community health survey aimed at addressing inequities in Massachusetts
The results will help the state figure out where healthcare resources are most needed. -
Only 1 in 5 people with opioid addiction get the medications to treat it, study finds
Overdose deaths from fentanyl and other opioids have surged but medications that could save thousands of lives "are sitting on the shelf unused," according to new research. -
Inequalities persist in who receives care for Alzheimer's disease
Black and Hispanic patients face a higher tendency to receive delayed or inadequate care for Alzheimer's. -
Can a healthy diet treat disease? Why some argue food is medicine
We chew over the growing number of organizations that provide medically tailored meals for people with chronic illness. -
How one nonprofit is integrating reading into pediatric care
Experts say reading to young children is beneficial not just for language development, but for a strong parent-child bond. -
Severe complications during childbirth nearly doubled over a decade in Massachusetts
Black women, people with intellectual disabilities and those over 40 have a much higher risk. -
FDA-approved Alzheimer's drug is 'just the beginning,' says MGH neurologist
While Leqembi has been proven to slow cognitive decline, it is only approved for use in patients with early stages of Alzheimer's.
